Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

New on Charts:

We've added Splits, Dividends, Earnings, and Earnings Estimates! Click on individual events to unveil more details.

If you prefer a cleaner view, easily disable them in Settings.

LIFE | Atyr Pharma Inc

Index- P/E- EPS (ttm)-1.23 Insider Own9.80% Shs Outstand57.05M Perf Week-1.86%
Market Cap90.14M Forward P/E- EPS next Y-1.01 Insider Trans4.00% Shs Float51.46M Perf Month-10.73%
Income-45.05M PEG- EPS next Q-0.24 Inst Own63.65% Short Float / Ratio0.80% / 1.69 Perf Quarter-26.85%
Sales10.39M P/S8.68 EPS this Y39.27% Inst Trans0.72% Short Interest0.41M Perf Half Y-24.76%
Book/sh1.86 P/B0.85 EPS next Y-3.60% ROA-39.39% Target Price23.20 Perf Year-42.34%
Cash/sh1.90 P/C0.83 EPS next 5Y13.00% ROE-46.72% 52W Range1.53 - 3.07 Perf YTD-27.85%
Dividend- P/FCF- EPS past 5Y42.86% ROI-37.37% 52W High-48.53% Beta1.26
Dividend %- Quick Ratio9.25 Sales past 5Y455.50% Gross Margin76.39% 52W Low3.27% ATR0.07
Employees70 Current Ratio9.25 Sales Q/Q- Oper. Margin-460.11% RSI (14)35.38 Volatility4.17% 4.01%
OptionableYes Debt/Eq0.14 EPS Q/Q49.46% Profit Margin-433.80% Rel Volume0.40 Prev Close1.59
ShortableYes LT Debt/Eq0.13 EarningsAug 09 AMC Payout- Avg Volume243.93K Price1.58
Recom1.33 SMA20-3.81% SMA50-13.04% SMA200-24.05% Volume98,578 Change-0.63%
Date Action Analyst Rating Change Price Target Change
Jul-05-23Downgrade Oppenheimer Outperform → Perform
Oct-12-21Initiated RBC Capital Mkts Outperform $22
Sep-21-21Initiated Piper Sandler Overweight $19
May-10-21Initiated Laidlaw Buy $18
Aug-17-20Upgrade H.C. Wainwright Neutral → Buy $13
Mar-04-20Initiated ROTH Capital Buy $15
Mar-02-20Initiated Oppenheimer Outperform $8
Feb-14-18Downgrade JP Morgan Neutral → Underweight
Sep-07-17Initiated Piper Jaffray Overweight $7
Dec-13-16Downgrade JP Morgan Overweight → Neutral
Jun-01-15Initiated Citigroup Buy $32
Sep-11-23 08:00AM
Aug-30-23 09:35AM
Aug-24-23 08:00AM
Aug-09-23 05:30PM
04:00PM Loading…
Jul-20-23 07:30AM
Jun-28-23 07:00AM
Jun-22-23 08:00AM
Jun-20-23 08:00AM
Jun-09-23 04:00PM
Jun-06-23 08:00AM
May-25-23 08:00AM
May-22-23 08:00AM
08:06AM Loading…
May-13-23 08:06AM
May-11-23 04:00PM
May-10-23 06:11AM
May-09-23 05:15PM
May-07-23 04:00AM
May-05-23 02:24PM
Apr-17-23 08:00AM
Mar-30-23 08:00AM
Mar-28-23 10:45AM
Mar-23-23 07:10AM
Mar-21-23 08:00AM
Mar-20-23 08:00AM
Mar-09-23 05:15PM
04:00PM Loading…
Mar-08-23 08:00AM
Mar-02-23 08:00AM
Mar-01-23 08:00AM
Feb-17-23 12:00PM
Feb-10-23 05:21AM
Feb-09-23 08:00AM
Feb-08-23 04:11PM
Feb-06-23 08:00AM
Jan-31-23 08:00AM
Jan-19-23 08:00AM
Jan-18-23 08:00AM
Dec-29-22 06:59PM
Dec-15-22 08:00AM
Nov-18-22 04:00PM
Nov-10-22 05:15PM
Nov-09-22 08:00AM
Nov-03-22 08:02AM
Oct-25-22 08:00AM
Oct-11-22 08:00AM
Oct-04-22 08:00AM
Sep-29-22 08:00AM
Sep-27-22 08:00AM
Sep-16-22 08:35AM
Sep-13-22 08:00AM
Sep-12-22 08:35AM
Sep-09-22 11:52AM
Sep-06-22 08:00AM
Sep-01-22 08:00AM
Aug-15-22 04:00PM
Aug-12-22 04:05PM
Aug-11-22 08:03AM
Aug-04-22 08:00AM
Jun-24-22 02:22PM
Jun-14-22 08:00AM
Jun-13-22 08:00AM
Jun-01-22 08:00AM
May-17-22 08:00AM
May-16-22 08:00AM
May-13-22 04:00PM
May-10-22 02:00PM
May-09-22 05:15PM
May-02-22 08:00AM
Apr-14-22 12:14PM
Apr-13-22 08:00AM
Apr-11-22 08:00AM
Apr-06-22 09:55AM
Apr-02-22 03:25PM
Apr-01-22 11:45AM
Mar-31-22 01:05PM
Mar-25-22 04:00PM
Mar-22-22 08:48PM
Mar-21-22 10:00AM
Mar-17-22 12:00PM
Mar-14-22 04:00PM
Mar-10-22 08:03AM
Mar-08-22 04:35PM
Mar-07-22 08:00AM
Mar-03-22 08:00AM
Mar-01-22 05:25PM
Feb-24-22 08:25AM
Feb-23-22 08:00AM
Feb-07-22 08:00AM
aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel biological pathways. Its product pipeline includes ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1, DARS-1. The company was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Shukla SanjayPresident and CEOJul 28Buy2.0115,00030,22476,173Aug 01 04:07 PM
SCHIMMEL PAULDirectorMay 10Buy2.25200,000450,000313,023May 11 09:00 AM
Broadfoot Jill MarieChief Financial OfficerFeb 06Sale2.361,5663,69615,460Feb 06 07:00 PM
Shukla SanjayPresident and CEONov 21Buy2.1410,00021,40550,798Nov 21 09:04 PM